Oncology
From the Journals
New model could boost BE screening, early diagnosis
The predictive model relies on factors readily available in EHRs and could potentially be automated using e-Trigger tools.
Latest News
Tumor-bed radiotherapy boost reduces DCIS recurrence risk
Regardless of the whole breast irradiation fractionation schedule, a 16 Gy tumor-bed boost halved the risk of DCIS recurrence at 5 years.
From the Journals
Fine-needle aspiration alternative allows closer look at pancreatic cystic lesions
Through-the-needle microforceps biopsy allow next-generation sequencing to be paired with histology for accurate results.
Latest News
Skip chemoRT in low-risk nasopharyngeal cancer?
There were no differences in efficacy for patients treated with radiation plus concurrent chemoradiation vs. radiation alone in a randomized trial...
Feature
In denial: When patients don’t want to believe they have cancer
“It appears there is a paucity of answers sadly.”
Feature
‘Flat denial’ can leave breast cancer patients with lasting scars
“I’ll just leave a little extra skin, in case you change your mind.”
From the Journals
How did cancer survivors fare early in the COVID-19 pandemic?
The rate of uninsured cancer survivors aged 18-64 years remained relatively stable in 2020 at 8%, compared with 8.8% in 2017-2019.
From the Journals
Reducing alcohol intake may reduce cancer risk
Study suggests cancer risk can be meaningfully altered by changing the amount of alcoholic beverages consumed.
Latest News
Second opinions on melanocytic lesions swayed when first opinion is known
Downward and upward shifts in severity from an accurate diagnosis are concerning because of the likelihood they will lead to overtreatment or...
From the Journals
Erlotinib promising for cancer prevention in familial adenomatous polyposis
After 6 months of weekly erlotinib, duodenal polyp burden was significantly reduced, with a mean percent reduction of 29.6%.
Latest News
Patients with cancer get valuable second opinion for free
Research shows that getting a second opinion can significantly change the course of a patient’s disease and treatment.